Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paraoxonase 1 (PON1) is a calcium-dependent hydrolytic enzyme primarily associated with high-density lipoprotein (HDL). It exhibits esterase and paraoxonase activities, including the ability to hydrolyze organophosphate compounds. PON1 plays significant roles in cardiovascular health, detoxification of organophosphates, and protection against oxidative stress.
Hydrolyzes organophosphates and other substrates, preventing oxidative stress and inflammation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paraoxonase 1 (PON1).